HRT FINANCIAL LP

Position in MGNX — Macrogenics Inc

CIK 1475597 NEW YORK, NY

Position in MGNX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$158,178

-$147,874 QoQ

Shares Held

54,733

-71.2% QoQ

Ownership

0.086%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $422,126,766 across 199 Biotechnology names. MGNX ranks #121 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	128,633	$42,560,800
2	IBRX	ImmunityBio, Inc.	3,925,446	$30,108,170
3	EXEL	Exelixis, Inc.	460,585	$19,754,490
4	IONS	Ionis Pharmaceuticals Inc	252,250	$18,941,452
5	MRNA	Moderna, Inc.	368,421	$18,715,786
6	ARGX	Argenx SE	18,754	$13,695,108
7	RARE	Ultragenyx Pharmaceutical Inc.	613,229	$12,847,147
8	IOVA	Iovance Biotherapeutics, Inc.	3,486,299	$12,236,909

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$158,178	54,733	-71.2%	Shares	Defined	2026-05-14
2025-12-31	$306,052	190,095	+85.1%	Shares	Defined	2026-02-12
2025-06-30	$124,283	102,714	+229.5%	Shares	Defined	2025-08-14
2025-03-31	$39,585	31,170	-58.5%	Shares	Defined	2025-05-15
2024-06-30	$318,928	75,042	-17.1%	Shares	Defined	2024-08-12
2023-09-30	$421,916	90,540	-41.2%	Shares	Defined	2023-11-13
2023-06-30	$824,295	154,074	-33.6%	Shares	Defined	2023-08-11
2023-03-31	$1,662,916	231,927	+66.8%	Shares	Defined	2023-05-12
2022-12-31	$932,777	139,013	-17.9%	Shares	Defined	2023-02-10
2022-09-30	$586,075	169,386	-49.3%	Shares	Defined	2022-11-14
2022-06-30	$985,364	334,022	+355.7%	Shares	Defined	2022-08-12
2021-12-31	$1,176,400	73,296	-21.4%	Shares	Defined	2022-02-14
2021-09-30	$1,953,869	93,308	+1108.0%	Shares	Defined	2021-11-15
2021-03-31	$246,009	7,724	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.